SCHEDULE: FMR LLC Boosts Stake in Cargo Therapeutics to 15%

FMR LLC and Abigail P. Johnson have disclosed a 15.0% beneficial ownership stake in Cargo Therapeutics Inc., holding 6,916,945 shares of common stock as of June 30, 2025.

Summary

• FMR LLC and Abigail P. Johnson reported beneficial ownership of 6,916,945 shares of Cargo Therapeutics Inc. common stock.
• This ownership represents 15.0% of Cargo Therapeutics Inc.'s outstanding common stock.
• FMR LLC holds sole voting power over 6,911,876 shares and sole dispositive power over 6,916,945 shares.
• Abigail P. Johnson holds sole dispositive power over 6,916,945 shares.
• The filing is a Schedule 13G, indicating the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
• The beneficial ownership is held through various FMR LLC subsidiaries and affiliates, including FIAM LLC, Fidelity Institutional Asset Management Trust Company, and Fidelity Management & Research Company LLC.

Sentiment

Score: 6

Explanation: The filing indicates a significant institutional investment, which is generally positive for investor confidence, but it is a routine disclosure and does not contain new operational or financial performance data.

Positives

• Significant institutional investment from FMR LLC, a major asset manager, signals confidence in Cargo Therapeutics Inc.
• The investment is stated to be for ordinary course of business, not for control, suggesting a passive investment strategy.

Negatives

• No specific negative financial or operational information is disclosed in this type of filing.

Risks

• No specific risks related to Cargo Therapeutics Inc.'s operations or financial health are disclosed in this filing.
• Concentration of ownership by a large institutional investor could potentially influence future corporate actions, though the filing states the investment is not for control.

Future Outlook

No forward-looking statements or guidance regarding Cargo Therapeutics Inc.'s future performance or operations are provided in this filing.

Management Comments

• I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

Industry Context

This filing is a standard disclosure of a significant ownership stake by a large institutional investor. It does not provide specific industry trends or competitor analysis for Cargo Therapeutics Inc.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake by FMR LLC may increase investor confidence and potentially attract other institutional investors.
• Company Management: Awareness of a large institutional holder may influence strategic decisions, though the filing states the investment is not for control.

Next Steps

• No specific future actions or milestones for Cargo Therapeutics Inc. are mentioned in this filing. The reporting persons will file amendments if their beneficial ownership changes significantly.

Key Dates

Recommendation

This Schedule 13G filing indicates a significant 15.0% beneficial ownership by FMR LLC and Abigail P. Johnson in Cargo Therapeutics Inc. While a substantial institutional stake can be viewed as a positive signal of confidence, this filing is purely a disclosure of ownership and does not contain any financial performance data, strategic updates, or forward-looking guidance from Cargo Therapeutics Inc. that would justify a 'buy' or 'sell' recommendation. Investors should consider this information as part of a broader due diligence process, looking at the company's financial statements, pipeline, and market position before making investment decisions. Therefore, a 'hold' recommendation is appropriate as this filing alone does not provide new fundamental information to change an existing investment thesis.

Keywords

Cargo Therapeutics Inc., FMR LLC, Abigail P. Johnson, Schedule 13G, beneficial ownership, common stock, institutional investor, SEC filing